ORIGIN ENERGY LTD

OGFGY | $5.88 -42.98% 290

(0.0% 1d) (0.0% 1m) (7.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (6.74% volume)
Earnings Calendar:
Market Cap: $ 10,129,756,305
https://www.originenergy.com.au/
Sec Filling | Patents | 2721 employees

(AU) origin is proudly australia's leading integrated energy company – exploring, generating and delivering energy solutions locally and internationally. we deliver today's energy needs to more than 4 million electricity, natural gas and lpg customers, making us australia's largest energy retailer. with significant investments in gas exploration and renewable energy technologies such as geothermal, hydro, wind and solar, we're also searching for and creating tomorrow's energy solutions. we are committed to fostering a diverse and inclusive work environment. at origin, we live our purpose, principles, values and commitments. they guide our decisions and underpin everything we do. view our community guidelines here: http://bit.ly/1gqp6e9

eletrical solar energy renewable

add to watch list Paper trade email alert is off

Orora Limited/ADR

ORRYY | $16.0

Manufacturing

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-66.67% volume)
Earnings Calendar:
Market Cap: $ 1,690,703,584
https://www.ororagroup.com/
Sec Filling | Patents | n/a employees

(AU)

add to watch list Paper trade email alert is off

ADBRI Limited/ADR

ADLDY | $7.84 0% 120

Manufacturing

(0.0% 1d) (0.0% 1m) (99.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (5.17% volume)
Earnings Calendar:
Market Cap: $ 1,280,525,906
http://adbri.com.au/
Sec Filling | Patents | n/a employees

(AU)

add to watch list Paper trade email alert is off

Incannex Healthcare Ltd

IXHL | $2.42 0.0% 9.5K

Manufacturing

(0.0% 1d) (-6.9% 1m) (18.0% 1y) (0.0% 2d) (-0.4% 3d) (-18.8% 7d) (21.49% volume)
Earnings Calendar:
Market Cap: $ 38,412,933
https://impression.healthcare/
Sec Filling | Patents | 132 employees

(AU) medica... the only nhs-equivalent reporting solution in the uk through our nighthawk, dayhawk, and routine services, we are the leading independent uk provider of radiology reporting, delivering in excess of 1 million reports a year. our reputation has been built on the provision of high-quality, fast and cost-effective teleradiology reporting services with our clients’ needs at the centre of everything we do. medica is a designated body, providing support in all aspects for the radiologist to achieve gmc revalidation. the medical director, dr stephen davies, is the responsible officer. get the flexibility and rewards you deserve today with medica: medica is currently expanding its network of radiologists to help continue to deliver first class teleradiology reporting services to the nhs and independent healthcare providers. a medica radiologist benefits from the flexibility of working hours, the convenience of working from their own home and all within a comprehensive clinical

add to watch list Paper trade email alert is off

Cochlear Ltd / ADR

CHEOY | $102.62 0.45% 4.4K

Manufacturing

(0.0% 1d) (-6.7% 1m) (21.1% 1y) (0.0% 2d) (0.0% 3d) (-2.8% 7d) (171.76% volume)
Earnings Calendar:
Market Cap: $ 13,442,007,853
http://www.cochlear.com/
Sec Filling | Patents | n/a employees

(AU)

add to watch list Paper trade email alert is off

Propanc Biopharma, Inc.

PPCB | $0.0014 -41.86% 4.4M

Manufacturing

(0.0% 1d) (-58.1% 1m) (225.0% 1y) (0.0% 2d) (0.0% 3d) (-23.5% 7d) (-54.26% volume)
Earnings Calendar:
Market Cap: $ 167,069
https://www.propanc.com/
Sec Filling | Patents | 2 employees

(AU) propanc biopharma, inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in australia. its lead product is prp, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. the company has a research collaboration with university of jaã©n to commence the pop1 joint drug discovery program. the company was formerly known as propanc health group corporation and changed its name to propanc biopharma, inc. in april 2017. propanc biopharma, inc. was founded in 2007 and is based in camberwell, australia.

add to watch list Paper trade email alert is off